Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43


Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.

Pecenka C, Munthali S, Chunga P, Levin A, Morgan W, Lambach P, Bhat N, Neuzil KM, Ortiz JR, Hutubessy R.

PLoS One. 2017 Dec 27;12(12):e0190006. doi: 10.1371/journal.pone.0190006. eCollection 2017.


Rationale and opportunities in estimating the economic burden of seasonal influenza across countries using a standardized WHO tool and manual.

Chaiyakunapruk N, Kotirum S, Newall AT, Lambach P, Hutubessy RCW.

Influenza Other Respir Viruses. 2018 Jan;12(1):13-21. doi: 10.1111/irv.12491. Epub 2017 Nov 16.


WHO guide on the economic evaluation of influenza vaccination.

Newall AT, Chaiyakunapruk N, Lambach P, Hutubessy RCW.

Influenza Other Respir Viruses. 2018 Mar;12(2):211-219. doi: 10.1111/irv.12510. Epub 2017 Dec 27.


Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.

Botwright S, Holroyd T, Nanda S, Bloem P, Griffiths UK, Sidibe A, Hutubessy RCW.

PLoS One. 2017 Oct 10;12(10):e0182663. doi: 10.1371/journal.pone.0182663. eCollection 2017.


Identification and Prioritization of the Economic Impacts of Vaccines.

van der Putten IM, Paulus AT, Evers SM, Hutubessy RC, Hiligsmann M.

Biomed Res Int. 2016;2016:6267343. doi: 10.1155/2016/6267343. Epub 2016 Dec 12. Review.


Cost-effectiveness thresholds: pros and cons.

Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, Hill SR.

Bull World Health Organ. 2016 Dec 1;94(12):925-930. Epub 2016 Sep 19.


Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?

Jit M, Hutubessy R.

Appl Health Econ Health Policy. 2016 Jun;14(3):245-52. doi: 10.1007/s40258-016-0224-7.


Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.

Sundaram N, Schaetti C, Merten S, Schindler C, Ali SM, Nyambedha EO, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.

BMC Public Health. 2016 Jan 14;16:36. doi: 10.1186/s12889-016-2710-0.


A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.

Ngabo F, Levin A, Wang SA, Gatera M, Rugambwa C, Kayonga C, Donnen P, Lepage P, Hutubessy R.

Vaccine. 2015 Dec 16;33(51):7357-7363. doi: 10.1016/j.vaccine.2015.10.022. Epub 2015 Oct 29.


Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.

Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O.

Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2.


The broader economic impact of vaccination: reviewing and appraising the strength of evidence.

Jit M, Hutubessy R, Png ME, Sundaram N, Audimulam J, Salim S, Yoong J.

BMC Med. 2015 Sep 3;13:209. doi: 10.1186/s12916-015-0446-9. Review.


Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.

Jauregui B, Garcia AG, Bess Janusz C, Blau J, Munier A, Atherly D, Mvundura M, Hajjeh R, Lopman B, Clark AD, Baxter L, Hutubessy R, de Quadros C, Andrus JK.

Vaccine. 2015 May 7;33 Suppl 1:A28-33. doi: 10.1016/j.vaccine.2014.10.090.


Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization.

Jit M, Dang TT, Friberg I, Hoang VM, Pham Huy TK, Walker N, Nguyen VC, Tran ND, Toda K, Hutubessy R, Fox K, Nguyen TH.

Vaccine. 2015 May 7;33 Suppl 1:A233-9. doi: 10.1016/j.vaccine.2014.12.017.


Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.

van der Putten IM, Evers SM, Deogaonkar R, Jit M, Hutubessy RC.

BMC Public Health. 2015 Apr 10;15:356. doi: 10.1186/s12889-015-1638-0.


Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.

Levin A, Wang SA, Levin C, Tsu V, Hutubessy R.

PLoS One. 2014 Jun 26;9(6):e101114. doi: 10.1371/journal.pone.0101114. eCollection 2014.


Comparing sociocultural features of cholera in three endemic African settings.

Schaetti C, Sundaram N, Merten S, Ali SM, Nyambedha EO, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.

BMC Med. 2013 Sep 18;11:206. doi: 10.1186/1741-7015-11-206.


Sociocultural determinants of anticipated vaccine acceptance for acute watery diarrhea in early childhood in Katanga Province, Democratic Republic of Congo.

Merten S, Schaetti C, Manianga C, Lapika B, Hutubessy R, Chaignat CL, Weiss M.

Am J Trop Med Hyg. 2013 Sep;89(3):419-25. doi: 10.4269/ajtmh.12-0643. Epub 2013 Jul 22.


Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR.

Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Review.


Q&A--Economic analyses for vaccine introduction decisions in low- and middle- income countries.

Hutubessy R.

BMC Med. 2013 Mar 14;11:71. doi: 10.1186/1741-7015-11-71. No abstract available.

Supplemental Content

Loading ...
Support Center